×
-0.0277083333333332 -0.0277083333333332 -0.0277083333333332 -0.0277083333333332 -0.0277083333333332 -0.0277083333333332 -0.0208333333333332 -0.0555555555555555
Stockreport

3 Things In Biotech, June 11: Acceleron's Second Punch, Advaxis's Letdown, Seattle's New Hope [Seeking Alpha]

ADVAXIS (ADXS)  More Company Research Source: Seeking Alpha
Last advaxis earnings: 9/10 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.advaxis.com
PDF Summary Acceleron and Celgene land another big blow with their TGF blocker. Advaxis's bad news from the EMA not offset by good news for the FDA. Astellas and Seattle Genetics launch a key study for another antibody-drug conjugate. Welcome to another edition of 3 Things In Biotech You Should Learn Today, a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. Acceleron and Celgene land another big blow with their TGF blocker Company: Acceleron ( XLRN ) and Celgene ( CELG ) Therapy: Lustpatercept Disease: Beta-thalassemia News: Following on recent news that lustpatercept improved survival in patients with lower-risk myelodysplastic syndrome, XLRN and CELG have announced that the BELIEVE study also met its primary study endpoint of erythroid response, defined as a reduction of transfusion dependence of at least 33% from baseline. Lustpatercept also improved the rate of 50% reduction [Read more]

IMPACT SNAPSHOT EVENT TIME: ADXS
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
ADXS alerts

from News Quantified
Opt-in for
ADXS alerts

from News Quantified